| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.51B | 40.40B | 43.79B | 52.54B | 39.79B | 30.28B |
| Gross Profit | 8.34B | 8.20B | 9.13B | 14.41B | 8.73B | 6.51B |
| EBITDA | 3.06B | 2.93B | 3.54B | 7.91B | 4.25B | 2.85B |
| Net Income | 1.91B | 1.83B | 2.20B | 5.71B | 2.88B | 2.05B |
Balance Sheet | ||||||
| Total Assets | 19.47B | 19.88B | 21.21B | 21.81B | 16.54B | 11.53B |
| Cash, Cash Equivalents and Short-Term Investments | 11.28B | 10.72B | 9.93B | 5.10B | 7.03B | 6.44B |
| Total Debt | 670.03M | 689.16M | 1.05B | 1.07B | 980.70M | 862.43M |
| Total Liabilities | 5.33B | 4.97B | 6.73B | 8.28B | 8.14B | 6.05B |
| Stockholders Equity | 14.04B | 14.82B | 14.39B | 13.46B | 8.34B | 5.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.65B | 6.25B | -1.40B | 565.18M | 2.67B |
| Operating Cash Flow | 0.00 | 2.71B | 6.77B | -1.21B | 976.89M | 2.74B |
| Investing Cash Flow | 0.00 | -129.78M | -614.74M | -319.32M | -282.06M | -48.00M |
| Financing Cash Flow | 0.00 | -1.79B | -1.32B | -405.00M | -98.60M | -177.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥21.03B | 8.06 | ― | 3.09% | 4.92% | -27.88% | |
70 Outperform | ¥28.09B | 8.25 | ― | 3.86% | 1.18% | -5.05% | |
69 Neutral | ¥30.56B | 10.06 | ― | 3.82% | 1.22% | -5.35% | |
64 Neutral | ¥31.10B | 8.49 | ― | 4.69% | -1.06% | 3.51% | |
64 Neutral | ¥16.40B | 65.84 | ― | 3.66% | 8.62% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥58.22B | 12.19 | ― | 3.66% | 3.47% | -0.05% |